Strategies & Technologies Driving Drug Discovery to Market
Antibody Injection for Severe Asthma
March 5, 2009 7:09 am | News | CommentsMcMaster University researchers have found patients with a very severe asthma benefit from injections of the antibody, mepolizumab.
Drug Blocks Two Emerging Viruses
March 5, 2009 6:53 am | News | CommentsTwo highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria.
Benchtop Cell Culture System
March 5, 2009 5:51 am | Product Releases | CommentsHamilton Company released the BioLevitator 3-D Cell Culture System.
SPR Detection System
March 5, 2009 5:45 am | Product Releases | CommentsFUJIFILM Corporation launched the AP-3000 label-free surface plasmon resonance (SPR) detection system for fragment-based lead discovery (FBLD). It measures up to six samples simultaneously.
Laser Scanning Microscope
March 5, 2009 5:35 am | Product Releases | CommentsCarl Zeiss announced the LSM 700 Laser Scanning Microscope for confocal microscopy.
Closing the Lab Information Gap
March 5, 2009 5:02 am | by Kim Shah, VP Marketing & Business Development, Thermo Fisher Scientific, Informatics | Articles | CommentsIntegrating lab data into business enterprise systems can drive both research processes and business decisions.
New Hope for Sufferers of Muscle Wasting Diseases
March 5, 2009 4:50 am | News | CommentsAn experimental procedure that strengthens stem cells’ ability to regenerate damaged tissue could offer new hope to sufferers of muscle-wasting diseases such as myopathy and muscular dystrophy.
Wyeth Comments on Wyeth v. Levine Ruling
March 5, 2009 4:36 am | News | CommentsA Wyeth statement called the US Supreme Court’s ruling in Wyeth v. Levine "disappointing, not only for Wyeth, but for patients and public health in general".
Seeking Out Sepsis
March 5, 2009 4:26 am | by Mike May, PhD, Contributing Editor | Articles | CommentsSepsis, a blood-borne bacterial infection, can kill as many as 60 percent of the people who contract it.
A Model Dilemma
March 5, 2009 3:59 am | by Catherine Shaffer, Contributing Editor | Articles | CommentsCell-based toxicogenomics studies are emerging as an alternative to animal testing. But for now, animal models are the necessary choice.
Human vs. Rodent
March 5, 2009 3:37 am | by D. Lansing Taylor, PhD, Founder, President and CEO, Cellumen, Inc., Pittsburgh, PA. | Articles | CommentsIn vitro toxicity testing has been used for many years, but the predictive power for either rodent, or human toxic liability has not been demonstrated, until recently.
Court Ruling Could Hamper Drug Innovation
March 4, 2009 11:58 am | by Linda A. Johnson, AP Business Writer | News | CommentsA US Supreme Court ruling that federal approval of a drug is no protection from lawsuits in state courts could make drugmakers more cautious about safety issues and may lead them to halt development of some medicines.
Adventures in vivo
March 4, 2009 11:57 am | by James Netterwald, PhD, MT (ASCP), Senior Editor | Articles | CommentsIn vivo imaging technology developers and providers gear new features toward the drug discovery and development process.
Saving Time and Sample
March 4, 2009 11:29 am | by David Hayes, Director, Research and Development, Bioscience Division, Millipore Corporation | Articles | CommentsResearchers step up to multiplex bead-based platforms to detect proteins for target indentification through clinical analysis.
Helping Hands for Formulation
March 4, 2009 10:28 am | by Lindsay Hock, Associate Editor | Articles | CommentsWith a push to help clients get into the clinic faster and get their drugs on the market, contract formulators assist in all stages of the drug formulation process.
